Literature DB >> 18600577

Homomeric and heteromeric P2X3 receptors in peripheral sensory neurons.

Jill-Desiree Brederson1, Michael F Jarvis.   

Abstract

ATP contributes to nociceptive sensory processing by activating a family of ligand-gated ion channels, the P2X receptors. One of these, the P2X3 receptor, is highly localized on primary afferent neurons. In sensory neurons, P2X3 receptors function as homomeric (P2X3) and heteromeric (P2X2/3) channels. Exogenous application of ATP and related agonists excites peripheral and central nerves, and increases sensitivity to noxious stimuli. Specific targeting of P2X3 receptors by gene deletion and knockdown results in a hypoalgesic phenotype. In animal models of pain, pharmacological blockade of P2X3 receptors fully blocked specific types of chronic inflammatory and neuropathic pain. Peripheral nerve injury differentially alters functional expression of P2X3 receptors on small and large diameter primary afferent neurons. These data have delineated discrete roles for homomeric P2X3 and heteromeric P2X2/3 receptor activation in acute and chronic pain. Similar findings have also been generated from extensive research of the bladder urothelial-sensory neuron system. The urinary bladder is richly innervated by P2X3 receptor-containing neurons. Heteromeric P2X2/3 channels in the bladder contribute to both mechanosensitivity and nociceptive responses. Thus, both genetic and pharmacological approaches have provided converging evidence that activation of P2X3-containing channels is an important mediator of acute and persistent nociceptive signaling in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600577

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  13 in total

Review 1.  P2X receptors as drug targets.

Authors:  R Alan North; Michael F Jarvis
Journal:  Mol Pharmacol       Date:  2012-12-19       Impact factor: 4.436

2.  AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

Authors:  Joel R Gever; Rothschild Soto; Robert A Henningsen; Renee S Martin; David H Hackos; Sandip Panicker; Werner Rubas; Ian B Oglesby; Michael P Dillon; Marcos E Milla; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+.

Authors:  Mufeng Li; Shai D Silberberg; Kenton J Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

Review 4.  Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation.

Authors:  Elias Rawish; Harald F Langer
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

5.  2',3'-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents.

Authors:  Diego Dal Ben; Anna Marchenkova; Ajiroghene Thomas; Catia Lambertucci; Andrea Spinaci; Gabriella Marucci; Andrea Nistri; Rosaria Volpini
Journal:  Purinergic Signal       Date:  2016-10-18       Impact factor: 3.765

Review 6.  Visceral organ cross-sensitization - an integrated perspective.

Authors:  P R Brumovsky; G F Gebhart
Journal:  Auton Neurosci       Date:  2009-08-12       Impact factor: 3.145

7.  Astrocytic CX43 hemichannels and gap junctions play a crucial role in development of chronic neuropathic pain following spinal cord injury.

Authors:  Michael J Chen; Benjamin Kress; Xiaoning Han; Katherine Moll; Weiguo Peng; Ru-Rong Ji; Maiken Nedergaard
Journal:  Glia       Date:  2012-08-01       Impact factor: 7.452

Review 8.  Heteromeric assembly of P2X subunits.

Authors:  Anika Saul; Ralf Hausmann; Achim Kless; Annette Nicke
Journal:  Front Cell Neurosci       Date:  2013-12-18       Impact factor: 5.505

Review 9.  P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain.

Authors:  Jeffrey L Krajewski
Journal:  Neurotherapeutics       Date:  2020-10-02       Impact factor: 6.088

10.  Sensory neuronal P2RX4 receptors controls BDNF signaling in inflammatory pain.

Authors:  Sarah Lalisse; Jennifer Hua; Manon Lenoir; Nathalie Linck; François Rassendren; Lauriane Ulmann
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.